Jing Lü
Impact in
- Geriatrics and Gerontology top 1%
- Molecular Biology top 1%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Advanced biosensing and bioanalysis techniques
- Histone Deacetylase Inhibitors Research
Papers in
-
- Advanced biosensing and bioanalysis techniques 26
- RNA Interference and Gene Delivery 10
- Ubiquitin and proteasome pathways 8
-
- Cardiac Fibrosis and Remodeling 10
- Chemotherapy-induced cardiotoxicity and mitigation 9
- Co-authors
- Duanping Sun (39 shared papers)Yimin Qian (6 shared papers)Craig M. Crews (4 shared papers)Kanak Raina (4 shared papers)Andrew P. Crew (4 shared papers)Martha Altieri (4 shared papers)Hanqing Dong (4 shared papers)Kevin Coleman (4 shared papers)
- Journals
- Acta Pharmacologica Sinica (8 papers)Cancer Research (7 papers)Acta Pharmaceutica Sinica B (5 papers)Biosensors and Bioelectronics (5 papers)Blood (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jing Lü
182 papers receiving 7.0k citations
Jing Lü's Hit Papers
Peers
Comparison fields: 5 of 139
- Geriatrics and Gerontology 250
- Molecular Biology 4.3k
- Hematology 574
- Oncology 1.2k
- Cancer Research 487
Countries citing papers authored by Jing Lü
This map shows the geographic impact of Jing Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Lü more than expected).
Fields of papers citing papers by Jing Lü
This network shows the impact of papers produced by Jing Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Lü. The network helps show where Jing Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Jing Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4 Hit paper breakdown → | 2015 | 867 |
| 2 | PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer Hit paper breakdown → | 2016 | 676 |
| 3 | 1995 | 260 | |
| 4 | 2009 | 201 | |
| 5 | 2009 | 158 | |
| 6 | 2009 | 156 | |
| 7 | 2019 | 149 | |
| 8 | 2021 | 147 | |
| 9 | 2010 | 128 | |
| 10 | 2020 | 127 | |
| 11 | 2013 | 124 | |
| 12 | 2015 | 115 | |
| 13 | 2019 | 102 | |
| 14 | 2019 | 96 | |
| 15 | 2006 | 93 | |
| 16 | 2020 | 88 | |
| 17 | 2005 | 85 | |
| 18 | 2019 | 85 | |
| 19 | 2016 | 84 | |
| 20 | 2013 | 82 |
About Jing Lü
Jing Lü is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Materials Chemistry and Biomedical Engineering, having authored 192 papers that have together received 7.0k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (26 papers), Advanced Nanomaterials in Catalysis (16 papers), Electrochemical sensors and biosensors (13 papers), Sirtuins and Resveratrol in Medicine (12 papers), RNA Interference and Gene Delivery (10 papers), Cardiac Fibrosis and Remodeling (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (9 papers) and Ubiquitin and proteasome pathways (8 papers). The work is most often cited by research in Geriatrics and Gerontology (250 citations), Molecular Biology (4.3k citations), Hematology (574 citations), Oncology (1.2k citations) and Cancer Research (487 citations). Jing Lü has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Duanping Sun, Yimin Qian, Craig M. Crews, Kanak Raina, Andrew P. Crew, Martha Altieri, Hanqing Dong, Kevin Coleman, Jing Wang and James D. Winkler. Their work appears in journals such as Acta Pharmacologica Sinica, Cancer Research, Acta Pharmaceutica Sinica B, Biosensors and Bioelectronics and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.